Similarly, mRNA levels of Pgc1α were lowered in our cellular models of MASLD, while silencing MCU restored the reduced Pgc1α mRNA in hepatocytes exposed to OPA toxicity (Fig. S7C). The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.